US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
ETF
アメリカ
AMEX
VanEck Bitcoin ETF (HODL) 銘柄情報

VanEck Bitcoin ETF (HODL)

17.05

-0.92

(-5.12%)

終了 6月6日 5:00AM

17.20

0.15

(0.88%)

取引時間後: 8:59AM

VanEck Bitcoin ETF (HODL) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

17.20

( -4.28% )

買値

-

売値

-

出来高

4,684,772

16.715 日の範囲 17.61

17.05 52 週間の範囲 35.76

前日終値

17.97

始値

17.56

時刻

最終取引時間

平均取引量 (3 か月)

1,324,330

財務取引量

US$ 80,221,848

VWAP

17.124

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

21shares Launches TKNS, Its First Actively Managed Crypto ETF, Bringing Dynamic Digital Asset Exposure to U.S. Investors

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s leading issuers of crypto...

21shares Announces Distributions on TSUI and TDOT

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency...

21shares Survey Finds Firm Policy and Education are the Primary Gatekeepers to Financial Advisors’ Digital Asset Adoption

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) -- 21shares, in partnership with the FUSE Research Network, today...

21shares Launches THYP and TXXH, the First U.S. ETFs Tracking Hyperliquid

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s leading issuers of crypto...

21shares Launches TCAN, the First U.S. ETF Providing Exposure to the Canton Network

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s leading issuers of crypto...

21shares Announces Staking Distribution Schedule for TDOT and TSUI

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency...

21shares Announces Distributions on TETH and TSOL

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 424I -

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-3.44	-16.6666666667	20.64	20.99	17.05	1598589	19.05422561	SP
4	-5.31	-23.5895157708	22.51	23.23	17.05	1069512	20.90845453	SP
12	-3.46	-16.7473378509	20.66	23.23	17.05	1324330	20.64840823	SP
26	-8.38	-32.7599687256	25.58	27.7	17.05	2015873	21.93731652	SP
52	-12.72	-42.513368984	29.92	35.76	17.05	1715475	25.4895053	SP
156	-38	-68.8405797101	55.2	122.63	17.05	952662	32.96599366	SP
260	-38	-68.8405797101	55.2	122.63	17.05	952662	32.96599366	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
SCAGScage Future	US$ 0.8489 (196.61%)	92.75M
SPHLSpringview Holdings Ltd	US$ 5.38 (125.20%)	40.61M
NOTVInotiv Inc	US$ 0.1638 (89.15%)	1.07B
RMSGReal Messenger Corporation	US$ 1.809 (64.45%)	199.97M
STISolidion Technology Inc	US$ 35.50 (56.32%)	38.55M
NUWENewellis Inc	US$ 0.1625 (-62.30%)	50M
NYXHNyxoah SA	US$ 1.41 (-51.04%)	2.47M
CYPHCypherpunk Technologies Inc	US$ 0.5176 (-47.26%)	30.53M
TDICDreamland Ltd	US$ 0.2277 (-37.68%)	12.09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3.91 (-36.73%)	381.9k
NOTVInotiv Inc	US$ 0.1638 (89.15%)	1.07B
SNBRSleep Number Corporation	US$ 0.477 (36.25%)	305.13M
SMTKSmartKem Inc	US$ 0.419101 (30.97%)	232.19M
NVDANVIDIA Corporation	US$ 205.10 (-6.20%)	220.65M
RMSGReal Messenger Corporation	US$ 1.809 (64.45%)	199.97M

US Market News

US Market News 2分前

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA BerobenatideJune 6, 2026 9:00 AM
Business Wire Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in

Investor082

Investor082 2分前

They are all a bunch of BS artists! They have trapped many naive retail families over the years by providing false hope and expectations.

Investor082

Investor082 4分前

See you in 2028 then! LP is likely to abandon Eden before that at some point than secure a commercial certification in 2028.

Keep a ton of dry powder. Looking forward to you bragging about averaging down in the coming weeks and months, LOL! ;)

Investor082

Investor082 7分前

In that case, forget about 2026 and 2027. Likely 2028 as well. C lab and Eden won’t certified for commercial production until 2028 at the earliest. Its more likely they will abandon Eden than secure commercial certification even in 2028. Have fun with the endless dilution in pennies! ;)

WhiteOwl

WhiteOwl 8分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

hardlesson

hardlesson 11分前

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 11分前

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL!

Meanwhile outstanding shares ballooned to 5B+, LOL! ;)

WhiteOwl

WhiteOwl 12分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 15分前

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 16分前

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo 16分前

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 17分前

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 19分前

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 20分前

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen 20分前

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 20分前

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman 21分前

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather 21分前

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot 21分前

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 22分前

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke 25分前

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics 27分前

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

VanEck Bitcoin ETF

Bmo Selecttrust Conserva...

Class A2 Floating Rate N...

BetaShares Commodities B...

Lamperd Less Lethal (ID)

Mont Royal Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。